Has Azmi Atiya, MD received payments from drug or device companies?

Yes. Drug and device makers reported $18,862 in general payments to Azmi Atiya, MD across 254 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Azmi Atiya, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Azmi Atiya, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Azmi Atiya, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Northridge, CANPI 1639109648

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 90.7% of the total across 254 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 34 manufacturers reported payments, led by Abiomed at 30.0% of the total. 2025 is the largest year on record at $4,072, 2.5 times the $1,652 reported in 2019.

$18,862in general payments, 2019–2025

Across 254 payments — averaging $74.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abiomed$6K
Edwards Lifesciences$3K
Medtronic$3K
Abbott$2K
Atricure, Inc.$1K
Artivion, Inc.$925
plus $3K from 28 others

What the payments were for

Consulting fees$400%
Travel & lodging$1,7179%
Food & beverage$17,10491%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abiomed	47	$5,664
Edwards Lifesciences	33	$3,426
Medtronic(2 entities)	55	$3,102
Abbott	25	$2,084
Atricure, Inc.	17	$1,096
Artivion, Inc.	7	$925
Intuitive Surgical	8	$495
Getinge USA Sales, LLC	9	$247
Baxter Healthcare	6	$232
Corcym Inc	1	$170
E.r. Squibb & Sons, L.L.C.	3	$163
Bolton Medical Inc	1	$159
Kerecis Limited	2	$116
Johnson & Johnson	4	$84
Smith+Nephew	4	$74
Grifols USA, LLC	3	$69
Veran Medical Technologies, Inc.	3	$64
Chiesi USA, Inc.	2	$60
Micromed Inc	1	$60
Davol Inc.	2	$59
AstraZeneca	2	$58
Biomerieux Inc	2	$53
BD	2	$51
Stryker	1	$50
Lemaitre Vascular, Inc.	4	$44
Convatec Inc.	1	$40
La Jolla Pharmaceutical Company	1	$32
Integra Lifesciences Corporation	1	$30
Hemosonics LLC	1	$30
Zimmer Biomet	1	$30
Kls-martin L.p.	2	$28
Saxum Surgical, Inc.	1	$24
Musculoskeletal Transplant Foundation Inc.	1	$22
Biom'up SA	1	$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,862 in reported general payments places this provider in the 75th percentile of 546 thoracic surgery (cardiothoracic vascular surgery) providers in California.

See all thoracic surgery (cardiothoracic vascular surgery) providers in California →

Medicare billing

Part B allowed, 2024

$230,756

Medicare patients

217

Services billed

478

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other thoracic surgery (cardiothoracic vascular surgery) in Northridge

Thomas FogartyPortola Valley$3.7M
Steven GundryPalm Springs$1.6M
Armin KiankhooySaint Helena$941K
Ara KlijianMurrieta$916K
Gregory FontanaThousand Oaks$875K
Gansevoort DunningtonSaint Helena$764K
Wilson TsaiWalnut Creek$680K
Fernando FleischmanLos Angeles$608K
Harmik SoukiasianLos Angeles$577K
Ali KhoynezhadLong Beach$476K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →